| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women JM Baeten, D Donnell, P Ndase, NR Mugo, JD Campbell, J Wangisi, ... New England journal of medicine 367 (5), 399-410, 2012 | 3923 | 2012 |
| Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 C Celum, A Wald, JR Lingappa, AS Magaret, RS Wang, N Mugo, ... New England journal of medicine 362 (5), 427-439, 2010 | 625 | 2010 |
| HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention D Donnell, JM Baeten, NN Bumpus, J Brantley, DR Bangsberg, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (3), 340-348, 2014 | 409 | 2014 |
| Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1–serodiscordant couples: a prospective implementation study in Kenya and Uganda JM Baeten, R Heffron, L Kidoguchi, NR Mugo, E Katabira, EA Bukusi, ... PLoS medicine 13 (8), e1002099, 2016 | 224 | 2016 |
| Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial JR Lingappa, B Lambdin, EA Bukusi, K Ngure, L Kavuma, M Inambao, ... PloS one 3 (1), e1411, 2008 | 212 | 2008 |
| Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial JR Lingappa, JM Baeten, A Wald, JP Hughes, KK Thomas, A Mujugira, ... The Lancet 375 (9717), 824-833, 2010 | 202 | 2010 |
| Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial PM Murnane, C Celum, N Mugo, JD Campbell, D Donnell, E Bukusi, ... Aids 27 (13), 2155-2160, 2013 | 185 | 2013 |
| Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana CW Wester, S Kim, H Bussmann, A Avalos, N Ndwapi, TF Peter, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 336-343, 2005 | 160 | 2005 |
| Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: a prospective cohort study ST Roberts, J Haberer, C Celum, N Mugo, NC Ware, CR Cohen, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 73 (3), 313-322, 2016 | 120 | 2016 |
| Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention A Mujugira, JM Baeten, D Donnell, P Ndase, NR Mugo, L Barnes, ... PloS one 6 (10), e25828, 2011 | 115 | 2011 |
| Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa R Heffron, K Ngure, J Odoyo, N Bulya, E Tindimwebwa, T Hong, ... Gates open research 1, 3, 2018 | 107 | 2018 |
| Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study JR Lingappa, E Kahle, N Mugo, A Mujugira, A Magaret, J Baeten, ... PloS one 4 (4), e5272, 2009 | 107 | 2009 |
| Emerging evidence from a systematic review of safety of pre‐exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? DL Joseph Davey, J Pintye, JM Baeten, G Aldrovandi, R Baggaley, ... Journal of the International AIDS Society 23 (1), e25426, 2020 | 104 | 2020 |
| HIV transmission risk persists during the first 6 months of antiretroviral therapy A Mujugira, C Celum, RW Coombs, JD Campbell, P Ndase, A Ronald, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 72 (5), 579-584, 2016 | 102 | 2016 |
| Daily oral tenofovir and emtricitabine–tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1–uninfected men and women: a … C Celum, RA Morrow, D Donnell, T Hong, CW Hendrix, KK Thomas, ... Annals of internal medicine 161 (1), 11-19, 2014 | 82 | 2014 |
| Peer distribution of HIV self-test kits to men who have sex with men to identify undiagnosed HIV infection in Uganda: a pilot study S Okoboi, O Lazarus, B Castelnuovo, M Nanfuka, A Kambugu, A Mujugira, ... PLoS One 15 (1), e0227741, 2020 | 69 | 2020 |
| Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease N French, A Mujugira, J Nakiyingi, D Mulder, EN Janoff, CF Gilks JAIDS Journal of Acquired Immune Deficiency Syndromes 22 (5), 509-516, 1999 | 68 | 1999 |
| Effect of condom use on per-act HSV-2 transmission risk in HIV-1, HSV-2-discordant couples AS Magaret, A Mujugira, JP Hughes, J Lingappa, EA Bukusi, G DeBruyn, ... Clinical Infectious Diseases 62 (4), 456-461, 2016 | 63 | 2016 |
| Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial A Mujugira, AS Magaret, C Celum, JM Baeten, JR Lingappa, RA Morrow, ... The Journal of infectious diseases 208 (9), 1366-1374, 2013 | 62 | 2013 |
| Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception PM Murnane, R Heffron, A Ronald, EA Bukusi, D Donnell, NR Mugo, ... Aids 28 (12), 1825-1830, 2014 | 61 | 2014 |
